17-29593658-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152345.5(ANKRD13B):āc.37G>Cā(p.Glu13Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000146 in 1,424,348 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152345.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANKRD13B | NM_152345.5 | c.37G>C | p.Glu13Gln | missense_variant | 1/15 | ENST00000394859.8 | NP_689558.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANKRD13B | ENST00000394859.8 | c.37G>C | p.Glu13Gln | missense_variant | 1/15 | 2 | NM_152345.5 | ENSP00000378328.3 |
Frequencies
GnomAD3 genomes AF: 0.000173 AC: 26AN: 150586Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000261 AC: 23AN: 88274Hom.: 0 AF XY: 0.000282 AC XY: 14AN XY: 49646
GnomAD4 exome AF: 0.000143 AC: 182AN: 1273762Hom.: 0 Cov.: 30 AF XY: 0.000177 AC XY: 111AN XY: 627756
GnomAD4 genome AF: 0.000173 AC: 26AN: 150586Hom.: 0 Cov.: 31 AF XY: 0.000177 AC XY: 13AN XY: 73504
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2022 | The c.37G>C (p.E13Q) alteration is located in exon 1 (coding exon 1) of the ANKRD13B gene. This alteration results from a G to C substitution at nucleotide position 37, causing the glutamic acid (E) at amino acid position 13 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at